This was strong evidence that FGF9 is a driver of the aggressive phenotype of hepatoma/hepatocarcinoma cells, mediated via FGFR3‐IIIb and/or FGFR3‐IIIc. This evidence concerns the gene FGFR3 and hepatocellular carcinoma.